Gerber Kawasaki Wealth & Investment Management Has $3.18 Million Stake in iShares Dow Jones US Medical Dev. (IHI)

Share on StockTwits

Gerber Kawasaki Wealth & Investment Management lifted its position in iShares Dow Jones US Medical Dev. (BMV:IHI) by 27.0% during the 1st quarter, HoldingsChannel reports. The fund owned 13,740 shares of the company’s stock after buying an additional 2,920 shares during the quarter. Gerber Kawasaki Wealth & Investment Management’s holdings in iShares Dow Jones US Medical Dev. were worth $3,181,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in IHI. Nalls Sherbakoff Group LLC purchased a new position in iShares Dow Jones US Medical Dev. during the fourth quarter valued at approximately $30,000. Ellis Investment Partners LLC purchased a new position in iShares Dow Jones US Medical Dev. during the first quarter valued at approximately $31,000. We Are One Seven LLC purchased a new position in iShares Dow Jones US Medical Dev. during the fourth quarter valued at approximately $41,000. Enterprise Financial Services Corp purchased a new position in iShares Dow Jones US Medical Dev. during the first quarter valued at approximately $51,000. Finally, Covenant Multifamily Offices LLC purchased a new position in iShares Dow Jones US Medical Dev. during the first quarter valued at approximately $82,000.

IHI traded up $0.88 on Thursday, reaching $221.93. 880 shares of the company traded hands, compared to its average volume of 30. iShares Dow Jones US Medical Dev. has a 52-week low of $2,806.59 and a 52-week high of $3,563.30.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by Zolmax and is the property of of Zolmax. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://zolmax.com/investing/gerber-kawasaki-wealth-investment-management-has-3-18-million-stake-in-ishares-dow-jones-us-medical-dev-ihi/3085824.html.

Read More: Index Funds

Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Dow Jones US Medical Dev. (BMV:IHI).

Institutional Ownership by Quarter for iShares Dow Jones US Medical Dev. (BMV:IHI)

Receive News & Ratings for iShares Dow Jones US Medical Dev. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Medical Dev. and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

1&1 Drillisch  Given a €20.50 Price Target at Macquarie
1&1 Drillisch Given a €20.50 Price Target at Macquarie
$0.35 Earnings Per Share Expected for CBL & Associates Properties, Inc.  This Quarter
$0.35 Earnings Per Share Expected for CBL & Associates Properties, Inc. This Quarter
CROWN CASTLE IN/SH SH  Issues FY 2019 Earnings Guidance
CROWN CASTLE IN/SH SH Issues FY 2019 Earnings Guidance
Cardlytics  Rating Increased to Buy at Zacks Investment Research
Cardlytics Rating Increased to Buy at Zacks Investment Research
$446.01 Million in Sales Expected for Ferroglobe PLC  This Quarter
$446.01 Million in Sales Expected for Ferroglobe PLC This Quarter
Vericel Corp  Expected to Post Quarterly Sales of $24.30 Million
Vericel Corp Expected to Post Quarterly Sales of $24.30 Million


 
© 2006-2019 Zolmax.